Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?

Journal of Pharmacology and Experimental Therapeutics

Volumn 314, Issue 3, 2005, Pages 939-944

  Gibson, James E ^a   Taylor, David A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ARGININE; ARISTOLOCHIC ACID; CAFFEINE; CALCIUM; CIMICIFUGA RACEMOSA EXTRACT; COMFREY EXTRACT; DIIODOTHYRONINE; EPHEDRINE; GREEN TEA EXTRACT; HERBACEOUS AGENT; KAVA EXTRACT; MINERAL; NEW DRUG; NON PRESCRIPTION DRUG; NOREPHEDRINE; RED CLOVER EXTRACT; SABAL EXTRACT; SILVER; SILYBUM MARIANUM EXTRACT; USNIC ACID; VALERIAN; VITAMIN; VITIS VINIFERA EXTRACT; YOHIMBINE;

CONSUMER; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DRUG APPROVAL; DRUG EFFICACY; DRUG LABELING; DRUG MANUFACTURE; DRUG SAFETY; FOOD; FOOD AND DRUG ADMINISTRATION; HEALTH CARE; HUMAN; INJURY; LIVER INJURY; MEDICAL INFORMATION; NONHUMAN; PATENT; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SELF CARE; SIDE EFFECT; UNITED STATES; WELLBEING;

DIETARY SUPPLEMENTS; DRUG AND NARCOTIC CONTROL; DRUG LABELING; DRUGS, NON-PRESCRIPTION; HUMANS; LEGISLATION, FOOD; SAFETY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 23944484785     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.105.085712     Document Type: Review

References (14)

1. Barkan ID (1985) Industry invites regulation: the passage of the pure food and drug act of 1906. Am J Public Health 75:18-26.
2. Cohen MH (2003) Complementary and integrative medical therapies, the FDA and the NIH: definitions and regulation. Dermatol Ther 16:77-84.
3. Cohen MH, Hrbek A, Davis RB, Schachter SC, and Eisenberg DM (2005) Emerging credentialing practices, malpractice liability policies and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: a descriptive study of 19 integrative health care centers in the United States. Arch Intern Med 165:289-295.
4. Committee on the Framework for Evaluating the Safety of Dietary Supplements, Food and Nutrition Board, Board on Life Science, Institute of Medicine and National Research Council of the National Academies (2004) Dietary Supplements: A Framework for Evaluating Safety. The National Academies Press, Washington, DC.
5. FDA News (2004) FDA announces major initiatives for dietary supplements. FDA News PO4-P101.
6. Food and Drug Administration, HHS (2004) Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule. Fed Regist 69:6787-6854.
7. Hardy ML (2001) Herb-drug interactions; an evidence-based table. Intern Med Alert Suppl 2001 Jan 29.
8. Herr SM (2005) Food-medication interactions, in Herb-Drug Interaction Handbook (Ernst E and Young VSL eds), pp 1-418, Church Street Books, Nassau, NY.
9. Hunt JR (1996) Position of the American dietetic association: vitamin and mineral supplementation. J Am Diet Assoc 96:73-77.
10. Hunt JR and Dwyer J (2001) Position of the American dietetic association: food fortification and dietary supplements. J Am Diet Assoc 101:115-132.
11. Jang EH, Park YC, and Chung WG (2004) Effects of dietary supplements on induction and inhibition of cytochrome P450s protein expression in rats. Food Chem Toxicol 42:1749-1756.
12. Khatcheressian LAW (1999) Regulation of dietary supplements: five years of DSHEA. Food Drug Law J 54:623-644.
13. Levy AS, Derby BM, and Roe BE (1997) Consumer impacts of health claims: an experimental study. U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Washington, DC.
14. Morrow JD, Edeki TI, El Mouelhi M, Galinsky RE, Koveleske R, Noveck RJ, and Preiss C (2005) American Society for Clinical Pharmacology and Therapeutics position statement on dietary supplement safety and regulation. Clin Pharmacol Ther 77:113-122.